Australia's largest stock trading and investment forum Australia's #1 stock forum

UNS unilife corporation

0.00%

0.5¢

Possible Abbvie Deal, page-3

First 3 Last

Share
Profile

Follow
oslo

5,687 Posts.

21/02/15

22:23

Post #: 14796691
Share

Originally posted by laga ↑

I was trying to do some rough calculations on a possible deal for Humira (all numbers rounded).
This drug sells at about 2000$ per unit and has annual revenues of 10 billion $.

http://www.drugs.com/stats/humira
http://www.fiercepharma.com/special-reports/humira-best-selling-drugs-2013

This makes up for 5 million units a year.
At about 1$ pricing vor the Unifill this would result in only 5 million $ per year to Unilife.
According to my information Humira has to be injected every two weeks. This equates to ~190000 patients worldwide. I don't know the pricing of the Lisa Auto injector but as this is a more or less non recurring revenue (not accounting for new patients) and using 30$ per unit it would only result in ~ 6 million $ to Unilife.

Adding to this any exclusivity deal will of course improve the economics.

I got the impression that I am missing something essential but for now I am far more impressed by the Sanofi deal.

Anybody care to "improve" my calculations?

Cheers

Expand

UNS now the preferred supplier I would look at their current drugs and future drug pipeline.

http://www.abbvie.com/products/home.html

http://www.abbvie.com/research-innovation/pipeline.html

UNS Price at posting: 85.5¢ Sentiment: Hold Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

NMG

New Murchison Gold blasts off at Crown Prince as 'better than expected' results return

DMP

Is Domino's a steal after -25% plunge?

THL

Tourism Holdings says Liberation Day tariffs smashed US RV demand

KGD

Kula picks up unexplored niobium play in Malawi, with surface samples logged

I88

Infini Resources onto Phase 2 at Portland Creek after spotting 'widespread uranium'

Trump chides Powell as Goldman call for calm. The RBA must be nervous

Week 27 Wrap: 40% China tariffs?; ASX +10% FY25; US Amazon price spike

HotCopper Highlights, Week 27: G8 scalped, Domino’s drops the box, Gemlife brief hype & more

OSL

OncoSil wraps up recruitment for key pancreatic cancer trial

Listen: HotCopper Wire Podcast 016 – FY25 ended up not so bad... but Trump unpause is coming

First 3 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Possible Abbvie Deal, page-3

Top Stories

New Murchison Gold blasts off at Crown Prince as 'better than expected' results return

Is Domino's a steal after -25% plunge?

Tourism Holdings says Liberation Day tariffs smashed US RV demand

Kula picks up unexplored niobium play in Malawi, with surface samples logged

Infini Resources onto Phase 2 at Portland Creek after spotting 'widespread uranium'

Trump chides Powell as Goldman call for calm. The RBA must be nervous

Week 27 Wrap: 40% China tariffs?; ASX +10% FY25; US Amazon price spike

HotCopper Highlights, Week 27: G8 scalped, Domino’s drops the box, Gemlife brief hype & more

OncoSil wraps up recruitment for key pancreatic cancer trial

Listen: HotCopper Wire Podcast 016 – FY25 ended up not so bad... but Trump unpause is coming

Featured News